News

Latest News and Updates

Imperial College research seminar | 22 May 2017 | London, UK

Natalie Vinkeles Melchers (Erasmus MC, Department of Public Health) was invited as a guest speaker to a research seminar at the Imperial Collage in London (UK). Natalie presented her work on the projected number of people with onchocerciasis-loiasis co-infection in Africa, from 1995 to 2025. Onchocerciasis, also known as river blindness, is a disease caused by infection with the nematode worm Onchocerca volvulus. Long-term infection may ultimately lead to blindness. Ivermectin is the drug used at a large-scale in onchocerciasis elimination programmes. However, for individuals that are co-infected with Loa loa, the African eye worm, ivermectin may cause severe adverse events (SAEs), potentially even death. The seminar presented estimations on how many people would be at risk of SAEs and how many people would thus benefit from alternative treatment strategies and drugs for onchocerciasis in L. loa endemic areas.

RGHI CommunicationsImperial College research seminar | 22 May 2017 | London, UK
Share this post

Related Posts